It is a pharma private limited company based in Kukatpally, Telangana, India, established in 2017.
2017 | Kukatpally, Telangana, India | ActiveSerind Pharma Private Limited, a active private limited company, was established on 30 March 2017 in Kukatpally, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74999TG2017PTC116257. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.68 Cr.
It upholds a compliant status. Its leadership includes Sandhya Nandiraju (Director), Udayalakshmi Suresh (Director). Past directors included Satyanarayana Murthy Nandiraju. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H No.3-6-V/77, Plot No.77, Vivekanandanagar, Kukatpally, Telangana, 500072.
U74999TG2017PTC116257
116257
30 March 2017
₹2.00 Cr
₹1.68 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Serind Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sandhya Nandiraju | Director | 30 Mar 2017 | Current |
| Udayalakshmi Suresh | Director | 16 Jul 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 Jul 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Serind Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 10952.16% decrease in profit. The company's net worth observed a substantial decline by a decrease of 24.41%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Serind Pharma had a promoter holding of 50.15% and a public holding of 49.85%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Serind Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Serind Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Serind Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Udayalakshmi Suresh was appointed as a Director was appointed as a Director on 16 Jul 2025 & has been associated with this company since 4 months 14 days . was recorded as a recent event.
Serind Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Serind Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
The activity Sandhya Nandiraju was appointed as a Director was appointed as a Director on 30 Mar 2017 & has been associated with this company since 8 years 7 months . was completed.
The activity Serind Pharma Private Limited was registered on 30 Mar 2017 with Roc Hyderabad & aged 8 years 7 months as per MCA records. was completed.
The CIN of Serind Pharma Private Limited is U74999TG2017PTC116257.
Serind Pharma Private Limited is headquartered at H No.3-6-V/77, Plot No.77, Vivekanandanagar, Kukatpally, Telangana, 500072.
Serind Pharma Private Limited was incorporated on 30 March 2017.
The current directors of Serind Pharma Private Limited are
The primary industry of Serind Pharma Private Limited is Pharma.
Serind Pharma Private Limited is unlisted.
The authorized capital of Serind Pharma Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.68 Cr.
The compliance status of Serind Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX